And the FDA is a great organization never having made a mistake on purpose or otherwise with the trials of leronlimab or other companies. They can rubber stamp those they like that show nothing and are dangerous ...and Advisory Panel members can outright quit in disgust. You mean that FDA? Wonder what a poll of doctors and scientist worldwide would tell us??? Oh by the way boys, only two trial doses with a "never before issued letter". We won't sign the letter highlighting the one month results and negating the first and second week results. That FDA?
Of course this could be an anomaly. CytoDyn could be the lone wolf of pharmaceuticals and not statistically relevant. Despite it all, our saline solution is saving lives with the patients clearing all the hurdles. CYDY has made huge advances as the cards continue to be dealt. We are talking top line results and top line pay out, a jack pot and not a 13 dud no pot to pee in.
Market Data 
Markets 
AI
